Skip to main content
Year archive

Innate Pharma — 2013 filings

All 37 regulatory filings released by Innate Pharma (IPH) in 2013, sourced directly from the official regulator.

37 Filings
2013 Period
2013 filings (37)
Filing Released Lang
Nouveau nombre d'actions et de droits de vote au 2 décembre 2013
Share Issue/Capital Change
2013-12-02 French
Communiqué Français
Capital/Financing Update
2013-11-20 French
Press Releases
Capital/Financing Update
2013-11-20 English
131118_IPH_placement_privé
Share Issue/Capital Change
2013-11-18 French
Press Release
Regulatory Filings
2013-11-15 English
Communiqué de presse
Regulatory Filings
2013-11-15 French
Press Release
Regulatory Filings
2013-11-14 English
Ccommuniqué
Regulatory Filings
2013-11-14 French
Press Release
Regulatory Filings
2013-11-08 English
Communiqué IPH4102
Regulatory Filings
2013-11-08 French
131105_IPH_Chiffre_d_affaires_9_mois_2013
Earnings Release 9M 2013
2013-11-05 French
Press release
Regulatory Filings
2013-10-15 English
Communiqué Français
Regulatory Filings
2013-10-15 French
Appointment Nicolai Wagtmann
Board/Management Information
2013-10-02 English
Nomination Nicolai Wagtmann
Board/Management Information
2013-10-02 French
Résultats Semestriels 30 juin 2013
Interim / Quarterly Report H1 2013
2013-09-19 French
Interim financial report 2013
Interim / Quarterly Report H1 2013
2013-09-19 English
Rapport semestriel 2013
Interim / Quarterly Report H1 2013
2013-09-19 French
DSMB Effikir Français
Regulatory Filings
2013-09-17 French
DSMB Effikir English
Regulatory Filings
2013-09-17 English
INNATE PHARMA : Bilan semestriel du contrat de liquidité avec la Société de Bourse Gilbert Dupont
Regulatory Filings
2013-07-02 French
INNATE PHARMA : Assemblée Générale Mixte du 28 juin 2013
AGM Information
2013-07-01 French
INNATE PHARMA : nombre de droits de vote associés au 17 mai 2013
Share Issue/Capital Change
2013-05-29 French
INNATE PHARMA : number of shares outstanding as well as its voting rights as at May 17, 2013
Share Issue/Capital Change
2013-05-29 English
Innate Pharma annonce la tenue de son assemblée générale annuelle le 28 juin 2013 à Marseille
AGM Information
2013-05-28 French
Innate pharma to hold its annual general meeting of shareholders on june 28, 2013, in Marseille, France
AGM Information
2013-05-28 English
INNATE PHARMA ANNOUNCES 1Q2013 REVENUE AND CASH IN LINE WITH EXPECTATIONS
Earnings Release Q1 2013
2013-05-07 English
INNATE PHARMA ANNONCE SON CHIFFRE D'AFFAIRES ET SA TRÉSORERIE AU 31 MARS 2013, EN LIGNE AVEC SES PRÉVISIONS
Earnings Release Q1 2013
2013-05-07 French
Rapport annuel et Document de référence 2012
Audit Report / Information FY 2012
2013-05-06 French
INNATE PHARMA : Nouvelles données précliniques présentées sur les programmes propriétaires ciblant TLR3 et KIR3DL2
Regulatory Filings
2013-04-12 French
INNATE PHARMA presents new data for proprietary programs targeting TLR3 and KIR3DL2
Regulatory Filings
2013-04-12 English
ANNUAL RESULTS FOR 2012: SIGNIFICANT ADVANCE FOR FOUR DRUG CANDIDATES AND STRONG CASH POSITION
Earnings Release FY 2012
2013-03-05 English
RÉSULTATS 2012 : AVANCÉES IMPORTANTES DES QUATRE CANDIDAT-MÉDICAMENTS ET POSITION DE TRÉSORERIE SOLIDE
Earnings Release FY 2012
2013-03-05 French
INNATE PHARMA (Euronext Paris: FR0010331421 - IPH) REPORTS INCREASE IN ANNUAL REVENUE FOR 2012
Earnings Release FY 2012
2013-02-07 English
INNATE PHARMA SA (Euronext Paris: FR0010331421 - IPH) ANNONCE DES PRODUITS OPÉRATIONNELS EN HAUSSE EN 2012
Earnings Release FY 2012
2013-02-07 French
INNATE PHARMA : Full-year report on Innate Pharma's liquidity contract with Gilbert Dupont
Transaction in Own Shares
2013-01-04 English
INNATE PHARMA : Bilan annuel du contrat de liquidité d'Innate Pharma à la Société de Bourse Gilbert Dupont
Regulatory Filings
2013-01-04 French